Gene · 10014
Papers2,885
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,885
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The complex biology of aryl hydrocarbon receptor activation in cancer and beyond. | Biochem Pharmacol | 2023 | 37696456 | PubTator, text mining | PubMed |
| A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. | iScience | 2023 | 37694141 | PubTator, text mining | PubMed |
| Research on Xiaoyao Powder in the treatment of depression based on epigenetics and quality markers. | Front Neurosci | 2023 | 37694120 | PubTator, text mining | PubMed |
| miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach. | Int J Mol Sci | 2023 | 37686073 | PubTator, text mining | PubMed |
| Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas. | Int J Mol Sci | 2023 | 37686015 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| Mocetinostat activates Krüppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis. | JCI Insight | 2023 | 37681413 | PubTator, text mining | PubMed |
| Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review. | Cancer Rep (Hoboken) | 2023 | 37675821 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| PROTAC chemical probes for histone deacetylase enzymes. | RSC Chem Biol | 2023 | 37654508 | PubTator, text mining | PubMed |
| Roles of salt‑inducible kinases in cancer (Review). | Int J Oncol | 2023 | 37654200 | PubTator, text mining | PubMed |
| Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer. | Theranostics | 2023 | 37649598 | PubTator, text mining | PubMed |
| Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Signal Transduct Target Ther | 2023 | 37644009 | PubTator, text mining | PubMed |
| The AIDS and Cancer Specimen Resource (ACSR): HIV malignancy specimens and data available at no cost. | AIDS Res Ther | 2023 | 37641153 | PubTator, text mining | PubMed |
| Histone deacetylase 6's function in viral infection, innate immunity, and disease: latest advances. | Front Immunol | 2023 | 37638049 | PubTator, text mining | PubMed |
| Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C. | Viruses | 2023 | 37632052 | PubTator, text mining | PubMed |
| Histone Modification of Colorectal Cancer by Natural Products. | Pharmaceuticals (Basel) | 2023 | 37631010 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers. | Medicina (Kaunas) | 2023 | 37629714 | PubTator, text mining | PubMed |
| Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review). | Exp Ther Med | 2023 | 37614437 | PubTator, text mining | PubMed |
| Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation. | Exp Ther Med | 2023 | 37614424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10014/papers?page=11